A new kind of blood test promises to find cancer early—sometimes even before symptoms appear. The pitch is compelling: a single sample of blood could scan the body for dozens of different cancers at ...

Study finds major methodological differences across seven direct-to-consumer stool tests, producing taxonomic profiles as variable as those between individuals — limiting clinical use.

As the Centers for Medicare and Medicaid Services calls for public feedback on how to stop lab test fraud, experts say a ...

A laboratory test — or assay — developed in Sudbury, Ont., to measure the effectiveness of chemotherapy is one step closer to ...

Keros Therapeutics will use the Massachusetts General Hospital MyMatch program to design a clinical trial testing rinvatercept for ALS.

A Decision Score provides prognostic discrimination for 10-year locoregional recurrence, with rising score associated with ...

But here's why you likely won't be seeing it in your doctor's office anytime soon.

Rhythm Biosciences has reached a major milestone with the first commercial sale of its blood-based ColoSTAT colorectal cancer ...

Multicancer assays leverage cfDNA methylation patterns to detect malignancy and infer tumor origin, with reported tissue-of-origin prediction approaching 87% accuracy in real-world experience. The 142 ...

Non-invasive prenatal testing (NIPT) is a simple blood test during pregnancy that helps detect rare genetic conditions early, ...

Waiv Raises $33M to expand AI precision oncology tests, strengthen pharma partnerships, and broaden global lab access globally.